SPRYARS PHARMACEUTICALS INC
CUSIP 82835W108 · common stock
3 tracked investors held ARS PHARMACEUTICALS INC (SPRY) at the end of Q3 2026, worth $53.5M in total. The largest holder was RA Capital Management, with 0.5% of its portfolio. Chuck Royce sold out of its position this quarter.
Holders · Q3 2026
3
New holders
0
Value held
$53.5M
Quarter-end price (est.)
$4.31
Investors holding SPRY · Q3 2026
| Investor | Weight | Shares | Value | Change |
|---|---|---|---|---|
| RA Capital Management RA Capital Management, L.P. | 0.47% | 10,860,977 | $46.8M | HOLD |
| Daniel Loeb Third Point LLC | 0.09% | 1,000,000 | $4.3M | HOLD |
| Adar1 Capital Management ADAR1 Capital Management, LLC | 0.10% | 560,999 | $2.4M | REDUCE-6.7% |
Sold out this quarter
| Investor | Prior weight | Prior shares | Prior value | Change |
|---|---|---|---|---|
| Chuck Royce | 0.00% | 54,024 | $432.7K | EXIT |